u/greta_nilsen

Slight fix: the number was 96.8, not 94.2.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Respectfully this is a sample of one presented as a finding.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

Sceptical. If this were true we would see it reflected in the data and we do not.

availability speculation must be flaired Speculation

testing the vendor claim versus testing your actual vial are two different posts

Crossposting this to c/meta because the people who need it are not reading this community.

Yeah, the VendorInvestigate number matching the claim is the actual signal.

New Zealand here. Waited 18 months on a list, gave up, went private, and the total cost was roughly what I expected.

3 months, 41kg, non-scale victory

You have restated the marketing copy. What is the actual substance here.

perimenopause and menopause weight physiology

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

private and public prescription routes differ

Came off after 77 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Not convinced.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

EU rules is usually a national question wearing a hat